{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T04:49:17Z","timestamp":1766551757676,"version":"3.44.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.xphs.2019.09.011","type":"journal-article","created":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T10:32:36Z","timestamp":1568457156000},"page":"3831-3841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Adjuvants as Delivery Systems in Antigen-Specific Immunotherapies"],"prefix":"10.1016","volume":"108","author":[{"given":"Lorena R.","family":"Ant\u00fanez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa M.","family":"Pressnall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cory J.","family":"Berkland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2019.09.011_bib1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.addr.2015.10.020","article-title":"Combining antigen and immunomodulators: emerging trends in antigen-specific immunotherapy for autoimmunity","volume":"98","author":"Northrup","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1016\/j.xphs.2019.09.011_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/cei.12226","article-title":"Multiple sclerosis treatment and infectious issues: update 2013","volume":"175","author":"Winkelmann","year":"2013","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"10.1016\/j.xphs.2019.09.011_bib3","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.tibtech.2018.02.008","article-title":"Antigen-specific tolerization and targeted delivery as therapeutic strategies for autoimmune diseases","volume":"36","author":"Shakya","year":"2018","journal-title":"Trends Biotechnol"},{"issue":"9","key":"10.1016\/j.xphs.2019.09.011_bib4","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.3390\/molecules14093286","article-title":"Squalene emulsions for parenteral vaccine and drug delivery","volume":"14","author":"Fox","year":"2009","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.xphs.2019.09.011_bib5","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1021\/mp2004862","article-title":"Correction to \u201ctargeted drug delivery to lymphocytes: a route to site-specific immunomodulation?\u201d","volume":"8","author":"Trevaskis","year":"2011","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2019.09.011_bib6","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nri824","article-title":"The future of antigen-specific immunotherapy of allergy","volume":"2","author":"Valenta","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.xphs.2019.09.011_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.iac.2015.08.009","article-title":"The use of adjuvants for enhancing allergen immunotherapy efficacy","volume":"36","author":"Chesne","year":"2016","journal-title":"Immunol Allergy Clin N Am"},{"issue":"4","key":"10.1016\/j.xphs.2019.09.011_bib8","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jdiacomp.2004.12.003","article-title":"Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes","volume":"19","author":"Agardh","year":"2005","journal-title":"J\u00a0Diabetes Complications"},{"issue":"1","key":"10.1016\/j.xphs.2019.09.011_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.clim.2010.10.004","article-title":"GAD-alum treatment induces GAD65-specific CD4+CD25highFOXP3+ cells in type 1 diabetic patients","volume":"138","author":"Hjorth","year":"2011","journal-title":"Clin Immunol"},{"issue":"4","key":"10.1016\/j.xphs.2019.09.011_bib10","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jaut.2009.10.005","article-title":"Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy","volume":"34","author":"Orban","year":"2010","journal-title":"J\u00a0Autoimmun"},{"issue":"5","key":"10.1016\/j.xphs.2019.09.011_bib11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.coi.2010.08.006","article-title":"Antigen-specific immunotherapy of autoimmune and allergic diseases","volume":"22","author":"Sabatos-Peyton","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.xphs.2019.09.011_bib12","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nri2153","article-title":"Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease","volume":"7","author":"Miller","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.xphs.2019.09.011_bib13","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nri2132","article-title":"Tolerogenic dendritic cells and the quest for transplant tolerance","volume":"7","author":"Morelli","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.xphs.2019.09.011_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.clim.2014.10.011","article-title":"Alternatively activated dendritic cells derived from systemic lupus erythematosus patients have tolerogenic phenotype and function","volume":"156","author":"Wu","year":"2015","journal-title":"Clin Immunol"},{"issue":"9","key":"10.1016\/j.xphs.2019.09.011_bib15","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.vaccine.2010.12.090","article-title":"Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes","volume":"29","author":"Calabro","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.xphs.2019.09.011_bib16","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nm1563","article-title":"Reverse signaling through GITR ligand enables dexamethasone to activate Ido in allergy","volume":"13","author":"Grohmann","year":"2007","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.xphs.2019.09.011_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0168-3659(02)00320-6","article-title":"A\u00a0novel controlled release formulation for the anticancer drug paclitaxel (Taxol\u00ae): PLGA nanoparticles containing vitamin E TPGS","volume":"86","author":"Mu","year":"2003","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.xphs.2019.09.011_bib18","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.xphs.2019.09.011_bib19","doi-asserted-by":"crossref","first-page":"C25","DOI":"10.1016\/j.vaccine.2010.07.021","article-title":"Unmet needs in modern vaccinology: adjuvants to improve the immune response","volume":"28","author":"Leroux-Roels","year":"2010","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.xphs.2019.09.011_bib20","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1016\/j.vaccine.2011.09.061","article-title":"The mechanism of action of MF59 \u2013 an innately attractive adjuvant formulation","volume":"30","author":"O\u2019Hagan","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.xphs.2019.09.011_bib21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fimmu.2013.00138","article-title":"The dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunity","volume":"4","author":"Gallo","year":"2013","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.xphs.2019.09.011_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cytogfr.2007.10.004","article-title":"Dendritic cells and cytokines in human inflammatory and autoimmune diseases","volume":"19","author":"Blanco","year":"2008","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"10.1016\/j.xphs.2019.09.011_bib23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.autrev.2015.01.014","article-title":"Skewing dendritic cell differentiation towards a tolerogenic state for recovery of tolerance in rheumatoid arthritis","volume":"14","author":"Schinnerling","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.xphs.2019.09.011_bib24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.autrev.2014.10.010","article-title":"Role of dendritic cells in the initiation, progress and modulation of systemic autoimmune diseases","volume":"14","author":"Mackern-Oberti","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"33","key":"10.1016\/j.xphs.2019.09.011_bib25","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1016\/j.vaccine.2006.06.005","article-title":"Enhanced humoral and memory B cellular immunity using HPV16\/18 L1 VLP vaccine formulated with the MPL\/aluminium salt combination (AS04) compared to aluminium salt only","volume":"24","author":"Giannini","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.xphs.2019.09.011_bib26","first-page":"406","article-title":"Mechanism of immunopotentiation and safety of aluminum adjuvants","volume":"3","author":"HogenEsch","year":"2012","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.xphs.2019.09.011_bib27","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.vaccine.2007.11.054","article-title":"Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice","volume":"26","author":"Wack","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.xphs.2019.09.011_bib28","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.intimp.2012.05.003","article-title":"MF59 formulated with CpG ODN as a potent adjuvant of recombinant HSP65-MUC1 for inducing anti-MUC1+ tumor immunity in mice","volume":"13","author":"Yang","year":"2012","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"10.1016\/j.xphs.2019.09.011_bib29","doi-asserted-by":"crossref","first-page":"BR125","DOI":"10.12659\/MSM.881758","article-title":"Experimental study of the mechanism of tolerance induction in dexamethasone-treated dendritic cells","volume":"17","author":"Gong","year":"2011","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.xphs.2019.09.011_bib30","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1479-5876-11-128","article-title":"A\u00a0short protocol using dexamethasone and monophosphoryl lipid A generates tolerogenic dendritic cells that display a potent migratory capacity to lymphoid chemokines","volume":"11","author":"Garc\u00eda-Gonz\u00e1lez","year":"2013","journal-title":"J\u00a0Transl Med"},{"issue":"1","key":"10.1016\/j.xphs.2019.09.011_bib31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1021\/mp034002c","article-title":"Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles","volume":"1","author":"Panyam","year":"2004","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2019.09.011_bib32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0169-409X(02)00228-4","article-title":"Biodegradable nanoparticles for drug and gene delivery to cells and tissue","volume":"55","author":"Panyam","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"issue":"8","key":"10.1016\/j.xphs.2019.09.011_bib33","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.4049\/jimmunol.180.8.5402","article-title":"The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells","volume":"180","author":"Seubert","year":"2008","journal-title":"J\u00a0Immunol"},{"issue":"5","key":"10.1016\/j.xphs.2019.09.011_bib36","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1172\/JCI31720","article-title":"APC-derived cytokines and T cell polarization in autoimmune inflammation","volume":"117","author":"Gutcher","year":"2007","journal-title":"J\u00a0Clin Invest"},{"issue":"11","key":"10.1016\/j.xphs.2019.09.011_bib37","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.drudis.2009.02.009","article-title":"The path to a successful vaccine adjuvant \u2013 \u2018The long and winding road\u2019","volume":"14","author":"O\u2019Hagan","year":"2009","journal-title":"Drug Discov Today"},{"issue":"7","key":"10.1016\/j.xphs.2019.09.011_bib38","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1586\/14760584.2013.811188","article-title":"An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants","volume":"12","author":"Fox","year":"2013","journal-title":"Expert Rev Vaccines"},{"issue":"13","key":"10.1016\/j.xphs.2019.09.011_bib39","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.vaccine.2011.01.011","article-title":"Adjuvant System AS03 containing \u03b1-tocopherol modulates innate immune response and leads to improved adaptive immunity","volume":"29","author":"Morel","year":"2011","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.xphs.2019.09.011_bib40","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.addr.2003.12.005","article-title":"Tocol emulsions for drug solubilization and parenteral delivery","volume":"56","author":"Constantinides","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.xphs.2019.09.011_bib41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1208\/s12249-007-9014-8","article-title":"Design and evaluation of self-microemulsifying drug delivery system (SMEDDS) of tacrolimus","volume":"9","author":"Borhade","year":"2008","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"10.1016\/j.xphs.2019.09.011_bib42","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/1097-0169(200007)46:3<200::AID-CM5>3.0.CO;2-M","article-title":"Changes in the motility, morphology, and F-actin architecture of human dendritic cells in an in\u00a0vitro model of dendritic cell development","volume":"46","author":"Shutt","year":"2000","journal-title":"Cell Motil"},{"issue":"3","key":"10.1016\/j.xphs.2019.09.011_bib43","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1600-0897.2009.00726.x","article-title":"ORIGINAL ARTICLE: impact of female sex hormones on the maturation and function of human dendritic cells","volume":"62","author":"Segerer","year":"2009","journal-title":"Am J Reprod Immunol"},{"issue":"15","key":"10.1016\/j.xphs.2019.09.011_bib44","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.addr.2009.09.005","article-title":"Squalene: a natural triterpene for use in disease management and therapy","volume":"61","author":"Reddy","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"10.1016\/j.xphs.2019.09.011_bib45","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.vaccine.2003.08.048","article-title":"Cell death induced by vaccine adjuvants containing surfactants","volume":"22","author":"Yang","year":"2004","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.xphs.2019.09.011_bib46","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0264-410X(93)90190-9","article-title":"Adjuvants \u2014 a balance between toxicity and adjuvanticity","volume":"11","author":"Gupta","year":"1993","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.xphs.2019.09.011_bib47","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.toxlet.2011.03.001","article-title":"Progress in understanding adjuvant immunotoxicity mechanisms","volume":"203","author":"Batista-Duharte","year":"2011","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.xphs.2019.09.011_bib48","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.xphs.2019.09.011_bib49","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nm.2306","article-title":"Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity","volume":"17","author":"Flach","year":"2011","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.xphs.2019.09.011_bib50","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1021\/acs.molpharmaceut.6b00111","article-title":"Physiochemical properties of aluminum adjuvants elicit differing reorganization of phospholipid domains in model membranes","volume":"13","author":"Ant\u00fanez","year":"2016","journal-title":"Mol Pharm"},{"issue":"9","key":"10.1016\/j.xphs.2019.09.011_bib51","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1471-4914(01)02101-3","article-title":"Processing and presentation of antigens by dendritic cells: implications for vaccines","volume":"7","author":"Bhardwaj","year":"2001","journal-title":"Trends Mol Med"},{"issue":"12","key":"10.1016\/j.xphs.2019.09.011_bib52","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.4049\/jimmunol.1102868","article-title":"Lipopolysaccharide-activated dendritic cells: \u201cexhausted\u201d or alert and waiting?","volume":"188","author":"Abdi","year":"2012","journal-title":"J\u00a0Immunol"},{"issue":"16","key":"10.1016\/j.xphs.2019.09.011_bib53","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/0264-410X(95)00089-J","article-title":"Enhancement of humoral response against human influenza vaccine with the simple submicron oil\/water emulsion adjuvant MF59","volume":"13","author":"Ott","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.xphs.2019.09.011_bib54","doi-asserted-by":"crossref","first-page":"19570","DOI":"10.1038\/srep19570","article-title":"Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens","volume":"6","author":"Knudsen","year":"2016","journal-title":"Sci Rep"},{"issue":"30","key":"10.1016\/j.xphs.2019.09.011_bib55","doi-asserted-by":"crossref","first-page":"10501","DOI":"10.1073\/pnas.0804699105","article-title":"Molecular and cellular signatures of human vaccine adjuvants","volume":"105","author":"Mosca","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.xphs.2019.09.011_bib56","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/08916934.2017.1373766","article-title":"Effects of immunomodulators on the response induced by vaccines against autoimmune diseases","volume":"50","author":"Marciani","year":"2017","journal-title":"Autoimmunity"},{"issue":"4","key":"10.1016\/j.xphs.2019.09.011_bib57","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1017\/S1431927615013744","article-title":"Ultrastructural visualization of vaccine adjuvant uptake in\u00a0vitro and in\u00a0vivo","volume":"21","author":"Giusti","year":"2015","journal-title":"Microsc Microanal"},{"issue":"1","key":"10.1016\/j.xphs.2019.09.011_bib58","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","article-title":"T\u00a0cell subsets and their signature cytokines in autoimmune and inflammatory diseases","volume":"74","author":"Raphael","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.xphs.2019.09.011_bib59","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nri1256","article-title":"Dendritic cells: emerging pharmacological targets of immunosuppressive drugs","volume":"4","author":"Hackstein","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.xphs.2019.09.011_bib60","series-title":"Immunopotentiators in Modern Vaccines","first-page":"249","article-title":"Chapter 13 - MF59: a safe and potent adjuvant for human use","author":"Kommareddy","year":"2017"},{"issue":"1","key":"10.1016\/j.xphs.2019.09.011_bib61","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0022-1759(95)00273-1","article-title":"Physical state of the neuroantigen in adjuvant emulsions determines encephalitogenic status in the BALB\/c mouse","volume":"190","author":"M\u00e4\u00e4tt\u00e4","year":"1996","journal-title":"J\u00a0Immunol Methods"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354919305842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354919305842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:29:39Z","timestamp":1758360579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354919305842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":59,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0022354919305842"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2019.09.011","relation":{},"ISSN":["0022-3549"],"issn-type":[{"type":"print","value":"0022-3549"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvants as Delivery Systems in Antigen-Specific Immunotherapies","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2019.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}